Innovation versus Financialization in the US Pharmaceutical Industry

Innovation versus Financialization in the US Pharmaceutical Industry

The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collectiv......
fra 269,-
Tilgjengelig i 1 butikker
Frakt og levering

Produktinformasjon

The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collective and cumulative learning.'

Spesifikasjon

Produkt
ProduktnavnInnovation versus Financialization in the US Pharmaceutical Industry
MerkeOther Brand

Pris og prishistorikk

Akkurat nå er 269,- den billigste prisen for Innovation versus Financialization in the US Pharmaceutical Industry blant 1 butikker hos Prisradar. Sjekk også vår topp 5-rangering av beste økonomi og ledelse for å være sikker på at du gjør det beste kjøpet.